Results 41 to 50 of about 238,371 (341)

The Interplay between Adipose Tissue Properties and Levels of NT-proBNP in People with HIV

open access: yesJournal of Obesity, 2023
Objective. We aimed to assess the association between low N-terminal pro-brain natriuretic peptide (NT-proBNP) and body mass index (BMI), adipose tissue distribution, adiponectin, and HIV-specific risk factors among people with HIV (PWH). Methods.
Mads-Holger Bang Jacobsen   +9 more
doaj   +1 more source

Natriuretic peptides and integrated risk assessment for cardiovascular disease. an individual-participant-data meta-analysis [PDF]

open access: yes, 2016
BACKGROUND: Guidelines for primary prevention of cardiovascular diseases focus on prediction of coronary heart disease and stroke. We assessed whether or not measurement of N-terminal-pro-B-type natriuretic peptide (NT-proBNP) concentration could enable ...
Adam S, Butterworth   +53 more
core   +1 more source

Cardiac Magnetic Resonance Left Ventricular Filling Pressure Is Associated with NT-proBNP in Patients with New Onset Heart Failure

open access: yesMedicina, 2023
Background and Objectives: Cardiovascular magnetic resonance (CMR) is emerging as an important imaging tool for sub-phenotyping and estimating left ventricular (LV) filling pressure (LVFP).
Hosamadin Assadi   +7 more
doaj   +1 more source

Effects of canagliflozin on cardiovascular biomarkers in older adults with type 2 diabetes [PDF]

open access: yes, 2017
Background: Sodium glucose co-transporter 2 (SGLT2) inhibitors may reduce cardiovascular and heart failure risk in patients with type 2 diabetes mellitus (T2DM).
Butler, Javed   +6 more
core   +1 more source

Characterization of NT-proBNP in Human Urine [PDF]

open access: yesClinical Chemistry, 2009
Abstract Background: Urine amino-terminal probrain natriuretic peptide (NT-proBNP) concentrations may exclude the presence of heart failure and provide insight into renal clearance mechanisms for human NT-proBNP. We characterized the molecular forms of urine NT-proBNP detected by immunoassay.
Suetonia C, Palmer   +3 more
openaire   +2 more sources

Post-operative N-terminal pro-brain natriuretic peptide predicts in-hospital mortality after living donor liver transplantation

open access: yesTürk Kardiyoloji Derneği Arşivi, 2020
Objective: The post-operative serum level of N-terminal pro-brain natriuretic peptide (NT-proBNP) has been found to be associated with post-operative cardiovascular complications and mortality in high-risk surgeries.
İsmail Polat Canbolat   +3 more
doaj   +1 more source

The association of N-terminal pro-brain-type natriuretic peptide with hemodynamics and functional capacity in therapy-naive precapillary pulmonary hypertension: results from a cohort study

open access: yesBMC Pulmonary Medicine, 2017
Background N-terminal pro-brain-type natriuretic peptide (NT-proBNP) is currently used as a surrogate marker for disease severity in pulmonary hypertension (PH).
T. M. Berghaus   +4 more
doaj   +1 more source

Die Biomarker BNP und NT‑proBNP

open access: yesZentralblatt für Arbeitsmedizin, Arbeitsschutz und Ergonomie, 2023
ZusammenfassungDie vorliegende Übersicht über die Biomarker BNP und NT-pro-BNP wird im Rahmen der Serie „Biomarker“ des Zentralblatts für Arbeitsmedizin, Arbeitsschutz und Ergonomie publiziert, die sich mit dem immer häufigeren Gebrauch der Bestimmung von spezifischen Markern bei sog. Manager-Vorsorgen und Check-up-Untersuchungen beschäftigt.
Oremek, G. M.   +4 more
openaire   +1 more source

N-terminal prohormone brain natriuretic peptide (NT-proBNP) as a noninvasive marker for restrictive syndromes [PDF]

open access: yes, 2008
Constrictive pericarditis (CP) and restrictive cardiomyopathy share many similarities in both their clinical and hemodynamic characteristics and N-terminal prohormone brain natriuretic peptide (NT-proBNP) is a sensitive marker of cardiac diastolic ...
ARTEAGA, E.   +7 more
core   +2 more sources

BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?

open access: yesEuropean Respiratory Review, 2020
Despite the advent of new therapies and improved outcomes in patients with pulmonary arterial hypertension (PAH), it remains a life-shortening disease and the time to diagnosis remains unchanged.
Robert A. Lewis   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy